High efficiency adenovirus-mediated gene transfer to human dendritic cells

Blood

Volumn 91, Issue 2, 1998, Pages 392-398

  Dietz, Allan B ^a   Vuk Pavlović, Stanimir ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 4;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EXPRESSION VECTOR; GENE TRANSFER; HUMAN; HUMAN CELL; NORMAL HUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

EID: 0031962522     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.392.392_392_398     Document Type: Article

References (31)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
2. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096, 1996
3. Gabrilovich DI, Patterson S, Timofeev AV, Harvey JJ, Knight SC: Mechanism of dendritic cell dysfunction in retrovirual infection of mice. Clin Immunol Immunopathol 80:139, 1996
4. Patterson S, Gross J, English N, Stackpoole A, Bedford P, Knight SC: CD4 expression on dendritic cells and their infection by human immunodeficiency virus. J Gen Virol 76:1155, 1995
5. Inaba K, Metlay JP, Crowley MT, Steinman RM: Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172:631, 1990
6. Gong J, Chen D, Kashiwaba M, Kufe D: Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 3:558, 1997
7. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52, 1996
8. Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP: Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 170:111, 1996
9. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, Lotze MT: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1:1297, 1995
10. Tao M-H, Levy R: Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 362:755, 1993
11. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317, 1996
12. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87, 1996
13. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LDJ: DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2:1122, 1996
14. Alijagic S, Moller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D: Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25:3100, 1995
15. Henderson RA, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ: Human dendritic cells genetically engineered-to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 56:3763, 1996
16. Reeves ME, Royal RE, Lam JS, Rosenberg SA, Hwu P: Retroviral transductian of human dendritic ceils with a tumor-associated antigen gene. Cancer Res 56:5672, 1996
17. 5 promote adenovirus internalization but not virus attachment. Cell 73:309, 1993
18. Greber UF, Willetts M, Webster P, Helenius A: Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477, 1993
19. Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM, Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS: A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 4:17, 1997
20. Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Lau R, Dissette VB, Hu B, Chen AY, Glaspy JA, Economou JS: Genetic immunization for the melanoma antigen MART-1/MELAN-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res 57:2865, 1997
21. Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ: Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 158:3270, 1997
22. + dendritic cells. Proc Natl Acad Sci USA 93:2588, 1996
23. Radmayr C, Bock G, Hobisch A, Klocker H, Bartsch G, Thurnher M: Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients. Int J Cancer 63:627, 1995
24. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
25. + human blood dendritic cells for active tumor immunotherapy. Exp Hematol 25:232, 1997
26. Miltenyi S, Muller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231, 1990
27. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davidson BL, Welsh MJ: Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 272:6479, 1997
28. Zhou L-J, Tedder TF: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821, 1995
29. Gerber DJ, Pereira P, Huang SY, Pelletier C, Tonegawa S: Expression of αv and β3 integrin chains on murine lymphocytes. Proc Natl Acad Sci USA 93:14698, 1996
30. Salgaller ML, Tjoa B, Lodge PA, Murphy G, Ragde H, Kenny B, Boynton A: Monitoring of prostate-specific membrane antigen (PSMA)-restricted responses in patients treated with dendritic cells pulsed with PSMA-derived peptides. Proc Am Assoc Cancer Res 38:4138, 1997
31. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Klicbe K-O, Andreeff M, Champlin RE: Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89: 1133, 1997